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ABSTRACT 
PRODUCTION AND CHARACTERIZATION OF COMPOSITE NANO/MICRO 
SIZED PARTICLES BY RAPID EXPANSION OF SUPERCRITICAL 
SOLUTIONS (RESS) CO-PRECIPITATION 
by 
Beidi He 
Nanoscale composites of hexahydro-1, 3, 5-trinitro-1, 3, 5-triazine (RDX) and polymer 
binders were produced by co-precipitation using rapid expansion of supercritical 
solutions (RESS). The binders used in this study are poly (vinylidene fluoride-co-
hexafluoropropylene) (VDF-HFP22), polystyrene (PS) and 7-amino-4-methyl coumarin 
(AMC). The RDX/VDF-HFP22 and RDX/PS co-precipitated nanoparticles were 
characterized by Field Emission Scanning Electron Microscopy (FE-SEM) and 
Transmission Electron Microscopy (TEM). The average size of produced nanoparticles is 
ca. 100 nm. TEM analysis of RDX/PS nano-composite shows a core-shell structure with 
RDX as the core material and the shell consisting of the polymeric binder. X-ray Powder 
Diffraction (XRPD) analysis indicates polycristalline structure of RDX in the product 
with a crystallite size of 42 nm. The content of RDX in the composite particles is in the 
range 70-73% by mass as determined by Gas Chromatography-Mass Spectroscopy (GC-
MS) and by XRPD. 
Micronized composites of ibuprofen and bio-compatible polymer binders were 
produced by co-precipitation in rapid expansion of binary supercritical solutions (RESS). 
The binders used in this study are poly-L-lactic acid (PLLA), poly (lactic-co-glycolic 
acid) (PLGA), and polyethylene glycol (PEG). The recrystallized particles of pure 
ii
ibuprofen as well as produced by ibuprofen co-precipitation with a polymer binder were 
characterized by optical microscopy. The average ibuprofen particle sizes are 1-3 microns 
depending on the process conditions. The particle size increases proportionally to the 
cubic root of the solute concentration in the supercritical solution in CO2. The co-
precipitated ibuprofen/polymer particle size is in the range of 3-10 microns. In vitro 
dissolution rates were measured at ambient temperature as well as at 37 °C. Polymer 
coated ibuprofen particles produced by RESS co-precipitation dissolve in water at 
ambient temperature from 10 to 20 times faster than the original ibuprofen powder. At 
37 °C the dissolution is from 2 to 3 times faster compare to the original powder. The 
acceleration of the dissolution rate is due to the much smaller particle size as well as the 
presence of polymer layers which prevent particle agglomeration.  
PRODUCTION AND CHARACTERIZATION OF COMPOSITE NANO/MICRO 
SIZED PARTICLES BY RAPID EXPANSION OF SUPERCRITICAL 
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CHAPTER 1  
 INTRODUCTION  
1.1 Supercritical Fluid Technology for Particulate Matter Engineering 
Supercritical fluids have been widely studied for the last three decades on their 
applications in materials preparation and processing. One of the most distinguishable 
properties of supercritical fluids is the tremendous change in the solvation power upon 
variations of temperature and pressure. The solvation power is closely related to the 
density of a supercritical solution which significantly varies with pressure at a given 
temperature. By tuning the external temperature and pressure the solvation power 
changes dramatically, which makes supercritical fluid an ideal solvent for materials 
dissolution and precipitation.  
Supercritical fluid (SCF) technology has been widely used in particle 
engineering due to processing versatility unavailable with conventional solvent-based 
techniques. A wide range of chemical compounds can be chosen as supercritical 
solvents. Among them, carbon dioxide (CO2) has become the most widely used. 
Carbon dioxide is inexpensive, nontoxic, and has relatively mild critical conditions, 
making it especially suitable as a processing medium. 
Numerous SCF-based approaches have emerged for the formation of ultrafine 
particles. These technologies can be divided into two principal motifs. Some use SCFs 
as a solvent while the others use SCFs as an anti-solvent. Rapid expansion of 
supercritical solutions (RESS) technology is one of the most widely used processes 
2 
 
utilizing SCFs as the solvent, which has been employed for the production of 
ultra-fine nano-sized and micron-sized powders (1-7). The approach utilizes strong 
dependence of the solvent strength of the SCFs on both temperature and pressure. As 
a result, by variation the process parameters the size and the morphology of the 
precipitated material produced by RESS could be modified. The pre-expansion 
pressure and temperature control the solubility of the solute in the supercritical carbon 
dioxide, which control the particle size. The expansion nozzle geometry as well as 
temperature and pressure in the expansion vessel control the size as well as the 
morphology of the produced particles. Expansion of supercritical solutions leads to 
drastic pressure and temperature drops, resulting in the supersaturation levels above 
10
7
 (8). At such high supersaturations, formation of small particles is favored, as the 
critical nucleus size can be as small as a single molecule (9). In addition, since the 
pressure change travels at the speed of sound (10) right after the nozzle where most  
particles are formed, the uniform conditions might result in a relatively narrow 
particle size distribution.  
 The RESS method in producing small particles is limited by the material’s 
solubility in supercritical fluid. For processing materials that are poorly soluble in 
SCFs, a commonly used alternative is to use a SCF as an anti-solvent. Their 
effectiveness as an anti-solvent stems from their high diffusivity in liquids, whereby 
precipitation can be rapidly achieved by the expansion of the liquid solution with an 
SCF (11). Supercritical anti-solvent precipitation (SAS) technology is a common form 
of processing utilizing this phenomenon (12).  
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1.2 Supercritical Fluid Technique for Particle Coating 
Particle coating has attracted significant interest because by combining different 
materials having different physical and chemical properties to form composites, new 
functionality or improved properties of the known materials could be achieved. 
However, conventional wet coating method introduces organic solvents which are 
toxic and difficult to remove. In the case of dry coating (13), one requirement is that 
the core material and the coating material need to be pre-manufactured to form small 
particles. This imposes a strict limit on the particle size. Also, it stems from the 
application of dry coating process to form thin layer of coating film, and the process is 
complicated.  
Coatings of nano-sized powders encounters several complications. Traditional 
methods such as water-based slurry coating become much less effective with very 
small particles. One issue is the difficulty in the dispersion of nanoparticles as they 
commonly exhibit a strong tendency to form agglomerates. This can result in a very 
non-uniform distribution of binder in the coated material. Another complication stems 
from the poor stability of nanoparticles in liquid suspensions. Ostwald ripening, 
which becomes significant at such small particle sizes, can detrimentally alter the 
particle size distribution. In a study aimed at characterizing the microstructure of 
slurry coated nanocrystalline RDX, it was shown that during coating of this material 
with a wax binder, which was achieved by a traditional slurry coating process, the 
RDX underwent extensive ripening (14). 
Therefore, supercritical fluid technology is also applied in the field of small 
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particles coating. There are several types of techniques for particle coating using the 
supercritical fluid processing: Supercritical anti-solvent (SAS), Particles from gas 
saturated solutions (PGSS), and Rapid expansion of supercritical fluid (RESS). 
In SAS (15), the coating material is dissolved in a conventional organic 
solvent, in which the core particles are suspended. Then a high-pressure supercritical 
fluid is injected into the solution, which causes the solution to expand. In this process, 
the core material needs to be pre-manufactured and an organic solvent is involved. In 
PGSS (16), a supercritical fluid is saturated with a liquid coating material. The core 
particles are also suspended in the liquid coating material. Particles are formed by 
rapid expansion of the saturated solution through a nozzle. This process is operated at 
moderate pressures as compared to RESS. It needs the supercritical fluid to be highly 
soluble in the liquid phase, which makes amorphous polymers suitable to be the 
coating material. Again, the core material is also pre-manufactured.  
In RESS, the coating material would be extracted by a supercritical fluid to 
form a supercritical solution. Then the solution rapid expands through a nozzle. 
Deposition of thin, uniform coatings by expansion of supercritical solutions has been 
previously reported. Tsutsumi et al. (17) successfully used the RESS technology to 
coat paraffin wax onto submicron catalyst particles with a thickness of the paraffin 
layer of ca. 40 nm. Mishima et al. (18) employed the RESS process to effectively 
encapsulate ca. 15 μm protein particles in  polymers. Glebov et al. (19) used RESS 
to produce polymeric films on fused silica plates and metal (Al, Mg) powders. A key 
distinction of the approach investigated in this work is that the core material is formed 
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during the same processing step as the coating, while in the reported studies the core 
materials was pre-manufactured. 
Manufacturing of a composite material by dissolution of both components in 
supercritical fluid to make a binary solution had also been reported. In several studies 
(18, 20), a semi-batch process was used, where CO2 first was saturated with the 
ingredients (the drug and the coating material) in confined vessels. After that, the 
mixture of the solution was expanded through a nozzle. In this approach, the amount 
of the material produced in one cycle is limited by the saturators’ volumes as well as 
the solutes solubility in supercritical carbon dioxide. Moreover, in this approach, the 
conditions are changing during the expansion process which complicates the 
assessment of the impact of the process conditions on the product properties. 
In the approach used in this study, we developed a continuous extraction and 
expansion system which overcomes the restrictions associated with the limited 
volume as well as the limited solubility of the solutes in supercritical carbon dioxide. 
1.3 Particles Coating in Pharmaceutical Applications 
Bioavailability is an important factor in drug design and medical applications of a 
drug (21). Many successfully designed and synthesized prospective chemical 
substances either have limited functionality as drugs or are even completely useless 
because of their low bioavailability (22-24). One of the factors that limit 
bioavailability of some drugs is low solubility in water (25-27). For poorly 
water-soluble drugs, their rate of absorption in the gastrointestinal tract depends on 
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the dissolution rate. Therefore, enhancement of the dissolution rate might improve the 
efficiency of certain drugs in the biological environment. One of the ways to increase 
the dissolution rate is the reduction of the particle size. Micronization is one of the 
commonly used methods to improve the drug dissolution rate. Traditional methods for 
micronization include grinding, milling, and spray-drying. However, these approaches 
result in wide particle size distribution and often introduce undesirable organic 
solvent residue (28). Even much smaller particles, if manufactured, are to be protected 
from agglomeration. This involves usage of a bio-compatible excipient with good 
solubility in water. Such a formulation, consisting of a very small drug particles 
(micron and submicron range) mixed with a bio-compatible polymer matrix is 
expected to dissolve much faster than larger (10–100 μm) particles of a low solubility 
substance. 
However, production of such compositions using standard techniques 
encounter difficulties associated with the problems of homogeneous mixing of 
micronized powders (29-31). In this work we suggest a technology which allows 
preparation of homogeneously micronized mixtures in a single technological step. In 
addition, the proposed technology is free from organic solvents, which is beneficial 
both from the point of view of strict regulations on the residual organic solvents (32) 
as well as environmental contamination issues. 
Ibuprofen is a widely used pain relieving drug. However, this substance has 
poor solubility in water which has a negative impact on the drug performance. Low 
solubility delays the pharmaceutical action. To achieve faster response, the 
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formulations use larger amounts of the active pharmaceutical ingredients (5). The 
increase of the dissolution rate might mitigate the problem. Ibuprofen has a relatively 
high solubility in supercritical carbon dioxide (33). In this study we applied the 
technique to the production of micronized ibuprofen/biocompatible polymer 
composites.  
Among prospective substances to be used as supercritical fluid solvent, carbon 
dioxide has several advantages. Carbon dioxide is non-toxic, economic; the 
production can be arranged in an environmentally friendly closed loop process. 
Previous studies on exploration of RESS technology for drug micronization (34-37) 
had been reported. One of the major problem encountered is agglomeration of the 
produced particles (5). Attempts to sieve micronized ibuprofen produced by RESS 
through a 250 μm mesh or physically mixing it with lactose did not improve the rate 
of dissolution. A thin polymer coating of the micron-sized particles could protect the 
drug particles from agglomeration in the composition. In addition, utilization of a 
highly soluble polymer might facilitate separation of the particles in the process of 
dissolution. Such polymer coated micron and submicron particles could be produced 
by a modification of the RESS technology. Rapid expansion of binary supercritical 
solutions of a drug with a highly soluble biocompatible polymer could be a solution of 
the agglomeration problem. 
1.4 Objectives of Research 
In a preceding study, the RESS technology was employed to produce high quality and 
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purity nanocrystals of hexahydro-1, 3, 5-trinitro-1, 3, 5-triazine (RDX), a common 
military high explosive used in numerous munitions. The nanocrystalline form of 
RDX showed a dramatic decrease in the initiation sensitivity to mechanical stimuli 
including shock and impact, which are key sources of accidental initiation (38). High 
explosives are rarely used in their pure form, rather, coating with a polymeric or wax 
binder is typically required. In this work, an alternative method for encapsulating 
RDX nanocrystals with a binder was investigated. The aim was to augment the 
existing RESS process with in-situ coating of the newly formed RDX nanocrystals 
with a polymeric binder. To accomplish this, the earlier RESS method (1) was 
modified by dissolving a polymeric binder together with RDX in supercritical CO2. 
This would necessarily cause both solutes to co-precipitate during RESS. In order to 
verify whether the desired structure was obtained with core RDX nanocrystals coated 
with a thin polymeric layer, transmission electron microscopy was employed.  
In this work, the RESS technology was also employed to produce high quality 
and purity microcrystals of ibuprofen as well as ibuprofen and biopolymer composites 
using continuous rapid expansion of binary supercritical solutions. With the 
fundamental understanding of the structures and morphology obtained by the 
co-precipitation of RDX and polymer binders. The continuous RESS technique to the 
pharmaceutical application is scaled-up. Ibuprofen was known to have 1000 times 
higher solubility as compared to RDX in supercritical carbon dioxide. The 
experiments are designed to apply the continuous RESS method for ibuprofen and 
some bioavailable polymers co-precipitation. The dissolution kinetics of the produced 
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materials was studied to evaluate the pharmaceutical benefits. Comparison of the 
dissolution behavior of the co-precipitated material with the unprocessed ibuprofen 







CO-PRECIPITATION OF RDX AND POLYMERS COMPOSITE BY RESS 
2.1 Materials 
Pure RDX was obtained by recrystallization of commercial RDX from acetone to 
eliminate impurities (mainly 12% of HMX in the initial material). VDF-HFP22, a 
poly(vinylidene fluoride-co-hexafluoropropylene) copolymer with 22 mol % 
hexafluoropropylene, was purchased from 3M, with a purity of 99+%, and a MW of 
85,000 g/mol. Polystyrene was obtained by dissolution of Styrofoam #6 in toluene 
with subsequent precipitation (MW of ca. 250,000 g/mol, purity 99%). AMC 
(7-amino-4-methyl-coumarin) (99.9%) was purchased from AnaSpec Inc., with a 
purity of 99.9%. Common organic solvents were used as purchased. Acetone (99.5+%, 
ASC grade) was purchased from Sigma Aldrich. Toluene (99.9%, HPLC grade) was 
purchased from Fisher Scientific. Carbon dioxide (99.8+%, bone dry grade) was 
purchased from Scott Specialty Gases. Liquid CO2 was supplied in cylinders with a 
siphon tube and pressurized with helium to 103 bar. 
2.2 Experimental Set-up 
The experimental setup is schematically shown in Figure 2.1. It consists of a carbon 
dioxide supply system, a Thar P-50 dual piston pump (Thar Designs Inc.) with a 
maximum discharge pressure of 350 bar and a maximum flow rate of 50 g/min, an 
RDX extraction vessel (1.27 cm ID, 35 cm long), a binder extraction vessel (1.27 cm 





Figure 2.1  The experimental set-up. 1: CO2 cylinder (liquid CO2, pressurized with 
helium, equipped with educator tube); 2: Dual piston pump; 3,4,6: Ovens; 5: RDX 
extraction vessel; 7: Binder extraction vessel; 8: Nozzle; 9: Temperature monitor; 10: 
Expansion chamber. 
 
All connections are made of 3.175 mm OD stainless steel tubing and SS 
Swagelok unions. The two extraction vessels are heated by two temperature 
controlled ovens. The connecting tubings are heated by variac powered heating 
elements. Four K-type 3.175 mm thermocouples are used to measure temperatures of 
the system elements. The thermocouples were placed in the RDX extraction vessel, 
inside the connecting tubing between the two extraction vessels using a union tee 
fitting (Swagelok), inside the tubing after the second extraction vessel again using a 
union tee fitting, and inside the supply tubing 50 mm before the stainless steel 
expansion nozzle. The cylindrical expansion/collection vessel prevented the 
co-precipitated RDX/binder powders from being influenced by moisture from 
entrainment of ambient air. The expansion vessel is made of transparent acrylic resin 
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with a 40 mm ID and is 36 cm long. The nozzle has an orifice with the inner diameter 
of 100 μm and a length of 3 mm.  
Liquid carbon dioxide withdrawn through the dip tube on the supply cylinder 
was fed to the pump. The pump output pressure was chosen by adjusting the mass 
flow rate using the pump controller. The pump piston heads and the incoming carbon 
dioxide were chilled to -5 °C for maximum pumping efficiency. Downstream from 
the pump the liquid carbon dioxide was preheated to the desired temperature in an 
oven prior to being fed to the extraction vessels. The RDX and polymer extraction 
vessels were packed with 3 mm diameter glass beads on which the respective solutes 
were deposited. The beads were used to significantly increase the surface area to 
accelerate dissolution of polymers in supercritical CO2. In the first vessel, the glass 
beads were coated with solid RDX (by wetting with a solution of RDX in acetone 
with subsequent drying). In the second vessel, the beads were coated with a polymer 
binder (either VDF-HFP22 deposited from a solution in acetone or polystyrene 
deposited from a solution in toluene). Supercritical solution of RDX and the binder is 
transferred through a heated, 3.17 mm stainless steel tube to the nozzle assembly 
where it is expanded to ambient pressure. The nozzle was uniformly heated with 
embedded heating elements to prevent blockage due to accumulation of dry ice as a 
result of drastic cooling of the feed solution during expansion. The product is 






To preload the binder onto the glass beads in the vessel, 1 ml of binder solution (0.2 g 
VDF-HFP22 dissolved in 10 ml of acetone or 0.2 g polystyrene dissolved in 10 ml of 
toluene) was added drop-wise to the binder extraction vessel and dried in ambient air 
flow (vacuum pumped). RDX solutions were prepared by dissolving 0.4 g RDX in 10 
ml of acetone. The coating of the beads was performed in a similar manner, 2 ml of 
the RDX solution was added drop-wise to the RDX extraction vessel also filled with 
glass beads, followed by drying with ambient air flow for 2 min. After drying, the 
heaters were turned on to reach the desired temperatures. The RDX vessel 
temperature was varied in the range 70-80 °C. The binder vessel temperature was 
varied in the range 100-110 °C. The expansion nozzle was maintained at 50 °C. After 
temperature stabilization for ca. 10 min, the high-pressure dual piston pump was 
turned on and liquid CO2 was pumped at a constant flow rate. To collect adequate 
quantities of the products, typical runs lasted 15 min.  
The initial material collected on the bottom of the expansion vessel was solid 
carbon dioxide (powdered dry ice) with entrained nanoparticles of RDX/binder. The 
product was left for ca. 1 h for carbon dioxide to sublime. The residual powder on 
wax paper or glass substrates was weighed and stored for further characterization. The 
RDX and binder vessels were disconnected from the system and weighed before and 
after each run to monitor the rate of consumption of RDX and the binder. The 





Table 2.1  Summary of Co-precipitated Nano-particles Produced by RESS 




wt. % RDX 
I RDX 52 200 100 
II RDX/VDF-HFP22 48 200 70 
III RDX/PS 53 205 72 
IV RDX/PS 50 150 72 
V RDX/PS 51 130 72 
 
2.4 Physical Properties of Co-precipitated RDX/polymer Composite 
2.4.1 X-ray Powder Diffraction Analysis 
X-ray Powder Diffraction (XRPD) analysis of prepared materials was performed 
using a Philips PW3040 X-Ray Diffractometer. Cu Kα radiation was employed for 
crystal structure analysis as well as crystallite size analysis in the RDX/VDF-HFP22 
nano-composites. Furthermore, quantitative analysis of constituents in the product 
materials was performed with XRPD. 
For quantitative determination, samples of the precursor RDX from 1.2 to 90 
mg were scanned for calibration. The scattered intensity was recorded in the range 
26° ≤ 2 𝜃 ≤ 30° in steps of 0.008° with a counting time of 0.96 s per step. The RDX 
powder was dissolved in acetone (1.5 g RDX/20 g acetone). For calibration, one to 
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thirty drops of the RDX solution were placed on quartz plates; the weights of the 
produced polycrystalline RDX were measured after acetone evaporation. A 15 mm 
beam width, a 1/2° incident beam divergence slit, and a 1/2° diffracted beam 
antiscatter slit were used. The X-ray diffractograms of different mass of the RDX 





















Figure 2.2  XRPD pattern of precursor RDX. 
 
The major characteristic diffraction peaks of RDX are at 2 θ = 12.95, 25.21, 
26.77 and 32.17°, which are in conformity with the crystal faces of (111), (131), (113) 
and (223) of RDX (39). After Fourier transform smoothing and the background 
subtraction, the diffraction peaks were integrated. The peak area is increasing linearly 
with the mass of RDX (Figure 2.3).  
  












Figure 2.3  Calibration curve of the integrated RDX peak areas from XRPD 
measurements. RDX mass is in the range of 1.2-90 mg. 
 
The precursor RDX, the RESS recrystallized RDX (sample I), VDF-HFP22 
polymer, and the RESS co-precipitated RDX/VDF-HFP22 composite (sample II) were 
scanned by XRPD in series for crystal structure study. Specimens of each material 
(0.15 g) were scanned separately in a 4 cm long × 2 cm wide × 0.5 cm deep stainless 
steel sample holder. Data was recorded in the range 10° ≤ 2 𝜃 ≤ 45°, which is the 
full pattern range for standard RDX in the database (39) as shown in figure 2.4. The 
samples were scanned in steps of 0.019° with a counting time of 1s per step. A 15 mm 
beam width, a 1° incident beam divergence slit, and a 1° diffracted beam antiscatter 
slit were used. Figure 2.5 shows an expansion in the diffraction angle range of 26-30°. 
The XRD diffractogram of the VDF-HFP22 film shows amorphous broad halo which 
represented its average polymer chain separation at 2 θ = 12-22°. In Figure 2.4d, 
every single peak was broadened due to the small RDX crystallite size in the 
composite.  
 











































Figure 2.4  XRPD patterns of 0.15 g RDX precursor, RESS recrystallized RDX 






















































Figure 2.5  XRPD patterns in smaller angle range of 0.15 g RDX precursor, RESS 
recrystallized RDX (sample I), VDF-HFP22 and RESS co-precipitated 
RDX/VDF-HFP22 (sample II). 

















Figure 2.5 also showed amorphous broad halo as a background which 
represented the average chain separation of coated VDF-HFP22. Compared to the 
precursor (large) RDX crystals, the diffraction line in the nano-RDX is broadened and 
has lower peak intensity. By integrating the peak area of RDX/VDF-HFP22 in the 
diffraction angle range of 26-30°, the RDX mass content in the nano-composite was 
determined as about 73 wt.%. 
According to the Scherrer equation (40), the diffraction lines are broadened 
due to the small size of the crystallites. The crystallite dimensions can be calculated 
using equation 2.1: 
 





where Dv is the volume weighted crystallite size. The parameter K is the Scherrer 
constant, which is usually considered to be equal to 1; λ is the wavelength of the 
X-rays used; βs is the broadening due to the small crystallite size; θ is the X-ray 
diffraction angle. The broadening due to the microstrain in the crystals, βstr, as well as 
the broadening due to the instrument, βinst, (which is usually set to 0.07) should also 
be considered (41). Assuming that the shapes of the broadened diffraction peaks for 
both the size and the strain components are Lorentzian, the total integral breadth 
(defined as the ratio of the peak area to the peak height) is obtained by adding the 




𝛽𝑡 =  𝛽𝑠 +  𝛽𝑠𝑡𝑟 +  𝛽𝑖𝑛𝑠𝑡 (2.2) 
 
According to Stokes and Wilson (42), the broadening due to the microstrain can be 
estimated using equation 2.3: 
 
𝛽𝑠𝑡𝑟 = 4 𝜀 𝑡an (𝜃) (2.3) 
  
Here ε is a measure of the microstrain which usually originates from the crystal 
defects. 
Combining equations (2.1), (2.2), and (2.3), the Williamson-Hall plot (43) can be 
drawn:  
 
(βt – 0.07) cos (θ)
λ








Therefore, by plotting (βt - 0.07) cos(θ) / λ vs. 4 sin(θ) / λ, dv and ε can be 
determined. 
 
Table 2.2  Scherrer Peak Broading Analysis Parameters (Sample II in Table 2.1, 
Composite RDX/VDF-HFP22) 
2 θ 2 sin(θ)/λ FWHM (β=βstr+βs) β cos(θ)/λ 
/degree /nm
-1
 /degree /radians /nm
-1
 






















The full width at half maxima of the peaks (FWHM) for the four main peaks 
of the RDX scattering pattern at 12.95, 25.21, 26.77 and 32.17° (2θ) are listed in 
Table 2.2. 
The peaks were integrated and their areas were divided by the peak heights. 
After that, the instrument broadening factor was subtracted. Figure 2.6 shows the 
Williamson-Hall plots for RDX precursor (44), RESS produced nano-RDX (44), and 
co-precipitated composite RDX/VDF-HFP22. The volume-weighted RDX crystallite 
















Figure 2.6  Williamson-Hall plot for (a) RESS co-precipitated RDX/VDF-HFP22 
(material II), (b) RESS recrystallized RDX (44), and (c) unprocessed RDX (44). 
 










smaller than the particle size observed by SEM. This indicates that there are multiple 
RDX crystallites inside the composite particles. This observation is in accord with the 
previous study (at somewhat different conditions, 80 °C and 280 bar), where the 
crystallite size of the RESS recrystallized RDX was 44 nm (Figure 2.3b (44)). Both 
the nano-composite and nano-RDX crystallite size are much smaller than the 
crystallite site of unprocessed RDX (44). 
The Williamson-Hall plot for the composite nano-particles also indicate larger 
internal strain in the crystallites compared to the nano-RDX but smaller than in the 
precursor (as determined from the slopes) of the Williamson-Hall plot Figure 2.6. 
2.4.2 Gas Chromatography - Mass Spectroscopy Analysis 
Gas Chromatography (GC) with Mass Spectroscopy (MS) analysis of prepared 
materials was performed using an HP 6890 series GC and an HP 5973 MS using 
electron impact ionization. Ultra-high grade purity Helium (99.999%, Airgas) was 
used as the carrier gas. A 30 m × 0.25 mm ID × 0.25 μm film thickness HP-5MS 
capillary column was used. The column flow was 1.0 ml/min. The column 
temperature was held at 150 °C for 30 min. The injector temperature was 150 °C and 
the detector temperature was 250 °C. The inlet was fitted with a double tapered liner 
and set in splitless mode. The purge valve opened and split vent flow increased to 100 
ml/min at 1.5 min after the injection to sweep any vapors remaining in the liner out to 
the split vent. The mass spectra were acquired over the 12-550 m/z mass range. 
Standard solutions of RDX were prepared and analyzed to determine the 
















Figure 2.7  RDX five point calibration plot of m/z = 46, 75, 120, and 128 MS 
signals. 
 
RDX was identified correctly using the NIST mass-spectra database search. 
The retention time and the quantification ions which were used subsequently for RDX 
determinations are 15.4 min; and m/z = 128, 120, 75, and 46. All quantifications were 
based on the peak area of the MS signal. The stock solutions of RDX were made by 
weighing 0.1 g (± 0.0001 g) of RDX and dissolving it in 5 ml of acetone in a 
volumetric flask. The mass spectrums were taken and the retention times were 
determined at different concentrations of RDX in the solutions. The calibration 
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standards were prepared by diluting the stock solution with acetone in 1 ml 
volumetric flasks. Five calibration standards were made containing RDX at 
concentrations between 800 and 8000 μg/ml.  
Peak areas of the analytes were then used to construct the calibration curves as 
shown in Figure 2.7. Regression analysis was used to assess the linearity of the 
analytical method. Five point calibration curves were constructed which produced 
correlation coefficients (R
2
) greater than 0.994. The RESS co-precipitated 
RDX/VDF-HFP22 and RDX/PS composites were analyzed to determine the mass 
content of the two components. The RDX concentrations were determined using the 

















Figure 2.8  GC-MS total ion chromatograms for RDX standard solutions in the 
range of 0.8-8.0 mg/ml. 
 
The RDX peak has a retention time of 15.4 min. The same method was used to 
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analyze sample II RDX/VDF-HFP22 nano-composite (Figure 2.9), which was 
dissolved in acetone with concentration of 80 μg/ml, 100 μg/ml, and 2000 μg/ml, 
respectively. GC-MS analysis requires much smaller amounts of the powders (ca. 2 
mg vs. ca. 150 mg). By this analysis (based on the integration of the peak areas of 
ions with m/z values of 46, 75, 120, and 128), the RDX mass content in the 
RDX/VDF-HFP22 composite was determined as 70%, in good agreement with the 
XRD quantitative analysis, which yielded 73% RDX mass content. The RDX/PS 
nano-composite (sample III) and RDX/AMC nano-composite were evaluated using 
















Figure 2.9  GC-MS total ion chromatograms for RESS co-precipitated 
RDX/VDF-HFP22 nano-composite sample II (200 bar, 48 °C) dissolved in acetone 













Figure 2.10  GC-MS total ion chromatograms for RESS co-precipitated RDX/PS 









Figure 2.11  GC-MS total ion chromatograms for RESS co-precipitated RDX/AMC 
nano-composite dissolved in acetone with concentration of 1100 μg/ml. 
 
Time / min 
Time / min 
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By subtracting the background and integrating the peak area, the measured RDX mass 
content in RDX/PS and RDX/AMC nano-composite are ca. 72% and 80%, 
respectively. 
2.4.3 GC-MS Analysis on RDX/AMC Nanocomposite 
2.4.3.1 Preparation and Storage of Standards. Stock standard solutions of RDX 
(3000 µg ml
-1
) and AMC (1000 µg ml
-1
) were prepared in acetone. The solution was 
sonicated in an ultrasonic bath (20 min) until a homogeneous and clear solution was 
formed. The stock solution was stored at room temperature for a maximum of 1 
month. Before use, standard working solutions were prepared by diluting appropriate 














Figure 2.12  Total ion chromatogram of the RDX and AMC standards. 
Concentration of analytes injected: RDX 500 µg ml
-1















The temperature of the GC injector was held at 150 ºC. Temperature of the 
MS detector was at 230 ºC. The oven temperature was set at 150 ºC, held for 5 min, 
increased to 170 ºC at 5 ºC min
-1
, held for 2 min, then to 230 ºC at 8 ºC min
-1
 and held 
for 5 min. The peak areas were used to quantify the analytes.  
The chromatogram of the standard mixtures of RDX and AMC under the 
adopted GC conditions using the HP-5MS is shown in Figure 2.12. Good separation 
of RDX and AMC was achieved. No column degradation was observed.  
2.4.3.2 Linearity. The sensitivity of the GC method was tested by injecting standard 
mixtures of the analyte (25-3000 µg ml
-1
). The calibration curves obtained by plotting 
the integrated peak area against the concentration of the respective standards were 
found to be linear over the range 25-3000 µg ml
-1
. The correlations coefficients are 
0.9994 for RDX and 0.9972 for AMC (Table 2.3). Good linearity was obtained for the 















2.4.3.3 Reproducibility Study. The reproducibility of the retention time was assessed 
by injecting the same standard solution (25, 50, 100, 200, 300, 400, 600, 800, 1000 µg 
ml
-1
) over the period of 8 days. Each standard was injected 5 times, which resulted in 
total 45 data points. The relative standard deviation (RSD) for the retention time 
obtained for RDX is 0.37%, and for AMC is 0.97%. The low RSD values indicate that 
the retention times were highly reproducible. 
 
Table 2.3  Calibration Data of the GC Method Used 
Analyte Regression 
equation 
Linearity Correlation coefficient 
µg ml
-1





RDX y = 6.8×10
4
 x 25-3000 0.9994 
AMC y = 3.3×10
4 
x 25-1000 0.9972 
 
2.4.4 Evanescent Excitation Microscopy of RESS Co-precipitated RDX/AMC 
Powder 
The experimental set-up is shown in Figure 2.14. An attempt to gain information on 
the morphology of the particles produced by the method using optical microscopy was 
made. The idea of the experiment was as follows. By precipitation of a binary solution 
of RDX with a fluorescent dye and by comparing usual microscopic images with the 
images taken in the fluorescence one might derive some conclusions on whether there 




Figure 2.14  Evanescent excitation microscopy experiment set-up. 
To this end, the total internal reflection fluorescence microscopy was 
performed for RESS co-precipitated RDX/AMC nanoparticles. AMC 
(7-amino-4-methyl coumarin) is a highly fluorescent material which could be excited 
with a 351 nm laser light. Thin layers of the sample powders were placed on the 
diagonal face of a right angle fused silica prism.  The laser beam is entering the 
prism through a smaller face, is being refracted, completely internally reflected from 
the diagonal face, and lives though the second smaller face, as shown in Figure 2.14. 
Outside the diagonal face of the prism exponentially decaying electromagnetic wave 
is formed (evanescent wave). The effective thickness of the evanescent field is about 
the wavelength. This approach allows avoiding the illumination of the objective lens 
with the laser pulse, and provides sensitive detection of the fluorescence of the AMC 
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dye molecules. The fluorescence occurs at 422 nm (blue light). The image is recorded 
using the gated ICCD camera. 
Amino methyl coumarine (AMC) has short fluorescence lifetime of 1.9 ns (45). 
The gate width of the ICCD camera was 2 μs, the laser pulse was triggered within the 
gate.  The images were taken in fluorescence using laser excitation as well as 
common images in light scattering using traditional light sources.  
2.4.4.1 Sample Preparation. Nano-RDX/AMC samples made at 214 bar, 51.5 °C 
and 198 bar, 37.3 °C were examined. 0.1 mg of either powder was placed on the 
prism, 5 µl of acetone was used to spread the powder to make a flat surface to make a 
sample.  
Images of blank prism were acquired on daily bases  to make a blank 
comparison. All of the blank images had “zero” (less than 5 counts/pixel after 1000 









Figure 2.15  RESS co-precipitated nano RDX/AMC. Left – traditional microscopy; 
right – evanescent excitation, the images are taken in fluorescence. Photon counting 
maximum intensity: 205 counts/binned pixel. Gate width 2 µsec. gain 255, 
discrimination thresholds 175-700, 8×8 binning pixel, microscope magnification 
56×10 = 560. 
 
___ 
3 μm ___ 3 μm 
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Bulk RDX was also evaluated. It did not show any detectable fluorescence. In 
the photon counting mode, the maximum intensity of fluorescence was ca. 500 
counts/pixel. It should be noted, that the size of the particles shown in in Figure 2.15 
is not resolved, the particles are broadened by diffreaction and not perfect focussing. 
Therefore, the amount of matter could not be evaluated from these images.  
Three locations of each sample were examined. Comparing the optical 
microscopy images and the fluorescent microscopy images, all particles in the field of 
view are fluorescent as shown in Figure 3.0, which means all the particles contain 
AMC, no pure RDX was found. Although a number of images have been acquired, no 
more definitive conclusions about the particle morphology (such as the component 
partitioning and spatial distribution) have been derived. 
2.4.5 Scanning Electron Microscopy Analysis 
Microscopy of produced materials was performed using a LEO 1530VP Field 
Emission Scanning Electron Microscope (FE-SEM). Nanoparticles were deposited on 
a 1 cm × 1 cm glass slide, which was mounted on a 1.3 cm diameter aluminum stub 
using an adhesive carbon tape and were sputter coated with carbon to a thickness of 
ca. 200 Å using a Bal-Tec MED 020 HR Sputter Coater. The generated images are 
shown in Figure 2.16. Figure 2.16a shows the morphology and the size of the RESS 
recrystallized RDX nanoparticles. Figure 2.16b is the SEM micrograph of the sample 
II, produced with both RDX and VDF-HFP22 loaded in the vessels. As it can be seen, 
the RDX nanoparticles have a relatively narrow size distribution. The distribution 
functions were obtained by manually measuring each particle area using Image-Pro 
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Plus 6.0 software and calculating their equivalent diameter. For nano-RDX, the 
frequency was plotted vs. the particle diameter from 0 to 400 nm and the increment of 
50 nm. Total of 291 particles from three SEM images of the same sample were 
analyzed. The average particle size is 160 ± 25 nm. Figure 2.16b shows the SEM 
micrograph of the RESS co-precipitated RDX/VDF-HFP22 nanoparticles. The average 


























Figure 2.16  SEM micrographs of sample I, RESS recrystallized nano RDX made of 
0.16 g RDX at temperature 52 °C and pressure 200 bar (a) and sample II, RESS 
co-precipitated RDX/VDF-HFP22 nanoparticles made of 0.16 g RDX and 0.04 g 
VDF-HFP22 polymer at temperature 48 °C and pressure 200 bar (b). On the right hand 








Total of 447 particles from three SEM images of the same sample were 
analyzed. The particles produced by co-precipitation appear to agglomerate more 
readily, likely due to the presence of VDF-HFP22 polymer which has a relatively low 
glass transition temperature (Tg = -20 °C). At low glass transition temperatures, 
nanoparticles tend to agglomerate (46). The absence of individual particles in the 
images is a result of plasticization of the polymer by CO2 (46). By comparing the 
micrographs, it is apparent that the average particle size of RDX/VDF-HFP22 is ca. 
25-50 nm smaller than that of pure RDX. This could be due to the impeding of the 
RDX particle growth by the polymer layer. 

























Transmission Electron Microscopy of fabricated specimens was performed 
with a Philips CM20 cryo-TEM/STEM. Nano-RDX/VDF-HFP22 composite (sample 
II) powder was loaded onto a TEM grid and imaged using TEM under cryogenic 
conditions. A representative TEM micrograph of sample II RDX/VDF-HFP22 
nanoparticles (Figure 2.17) demonstrates the particles have near-spherical shape.  
The particle size is ca. 100 nm. Here, the distribution of the polymeric binder 
was not revealed due to the lack of contrast between the polymer and RDX. To 
circumvent the problem, heavy element staining is commonly employed, typically 
with RuO4. Ruthenium tetroxide was introduced as a differential stain. It is used to 
label aromatic moieties from aliphatic ones. It can react with certain polymers to 
enhance contrast during TEM imaging. It is a strong oxidizer and has shown 
penetration depth of 100 nm within 15 min of reaction time (47). However, 
VDF-HFP22 does not react with RuO4 and, therefore, another polymer must be used 
for enhanced structural determination of the RESS co-precipitated RDX composites. 
Polystyrene has been shown to be effectively stained by RuO4 (48). RuO4 vapor 
covalently opens aromatic rings in polystyrene, RuO2 nanocrystal deposit on 
polystyrene free surface. As polystyrene continuously exposed to RuO4 vapor, a 
continuous film of electrically conductive RuO2 forms, which reduce the overall 
contrast that obtained in transmission electron imaging. Therefore, polystyrene was 
chosen as an alternative to VDF-HFP22 in preparation of RDX/binder nanocomposites. 
The RDX/PS nanocomposite (sample III) prepared by RESS co-precipitation was 
exposed to ruthenium tetraoxide (RuO4) vapor (from 1 drop of 0.5 wt. % aqueous 
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RuO4 solution) at room temperature for 20 min and then analyzed using cryogenic 
TEM. The TEM micrographs of sample III RDX/PS nanoparticles with and without 




















Figure 2.18  TEM micrographs of RESS produced nanoparticles. Two micrographs 
on the left are the RESS co-precipitated sample III RDX/PS nano-composite (205 bar, 
53 °C): powder stained by RuO4 (a) and without staining (b). Two micrographs on the 
right are RESS recrystallized sample I nano-RDX (200 bar, 52 °C): powder stained by 
RuO4 (c) and without staining (d). 
 
RuO4 staining was very effective for enhancement of the contrast between 
200 nm 50 nm 







RDX and PS. The thin layer visible around the particles corresponds to the stained 
polystyrene. The TEM image (Figure 2.18a) clearly shows that the polystyrene layer 
completely covers the RDX core. The thickness of the dark PS coating is estimated as 
ca. 8 nm. Estimated weight fraction of the polymer from the film thickness is 30 ± 7% 
(which corresponds to the RDX weight fraction of 70 ± 7%), in excellent agreement 
with the GC-MS and XRPD determinations. From this analysis it can be concluded 
that a core/shell structure with RDX at the core is formed. In order to rule out the 
possibility of the dark layers shown in Figure 2.18a being solely due to the RuO4 
deposition, binder free RDX nanoparticles (Sample I) were treated similarly by RuO4 
vapor. After such treatment, no such layer is visible in the TEM images when no 
polymer is present (Figure 2.18c). The particles appearance is identical to that of 
RDX particles untreated by RuO4 (Figure 2.18d). This further confirms that the dark 
shells in the particle images shown in Figure 2.18a are composed of polystyrene 
Comparison of the TEM micrographs (Figure 2.18a) of stained RDX/PS 
nanocomposite particles and nano-particles of RDX indicates that PS evenly 
encapsulates the core. The average size of the RDX/PS nanocomposite particle is ca. 
150 nm. Samples of TEM images of stained RDX/PS produced at different pressures 
are shown in Figure 2.19. The coating layer is resolved for samples made at different 
pressures. The core-shell structure was stable and not influenced by the process 
conditions. 
2.4.7 Electron Energy Loss Spectroscopy in Transmission Electron 
Microscopy (TEM-EELS)  
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TEM-EELS is a powerful tool to analyze microstructures; it can reveal morphologies 
of different chemical elements contained in a microscopic object. In the 
RDX/VDF-HFP22 nano-composites, only RDX contains element oxygen, while only 

















Figure 2.19  TEM micrographs of RESS co-precipitated RDX/PS nano-composite 
stained by RuO4. a) sample III prepared at 205 bar, 53 °C. b) sample IV prepared at 
150 bar, 50 °C. c) sample V prepared at 130 bar, 51 °C. 
 
The Zero-loss micrograph of the agglomerate of the VDF-HFP22 coated RDX 
nanoparticles is shown in Figure 2.20a, the micrograph of oxygen mapping (RDX 
only) of the same sample is shown in Figure 2.20b. The size of the coated 
100 nm 100 nm 





RDX/VDF-HFP22 particles is estimated as ca. 50 nm from the zero loss micrograph. 
The oxygen mapping (Figure 2.20b) exhibits the same shape and morphology of the 
RDX nanoparticle agglomerate as the TEM Zero-Loss micrograph (Figure 2.20a). 











Figure 2.20  TEM-EELS micrographs of RESS co-precipitated RDX/VDF-HFP22 
nano-composite. (a) zero loss; (b) oxygen mapping. 
 
By comparing the Zero-loss and oxygen mapping micrographs, it is apparent 
that there is a thin layer of VDF-HFP22 covered outside of the RDX nanoparticles. In 
Figure 2.20a, the part inside the small square labelled “spatial drift” was used as 
reference for the software to automatically adjust for the drift during the collection of 
the spectrum; the part inside the “spectrum image” is the area chosen to acquire a 
higher spatial resolution spectrum. This area is sampled as an array of 160 × 40 points, 
and each point yields one EELS spectra. The whole sample spectrum and the 
elemental composition map were extracted based on the spectrum image. By roughly 







the composite area. Estimating the particle diameter as 100 nm, this leads to the 
coating layer thickness of 5 nm, in fair agreement with the thickness obtained by 





CO-PRECIPITATION OF IBUPROFEN 
AND POLYMERS COMPOSITE BY RESS 
3.1 Materials 
Ibuprofen (98+%, GC grade) was purchased from Sigma-Aldrich. Poly (L-lactic acid) 
(MW 50,000 g/mol) was purchased from Polyscience Inc. Poly (lactic-co-glycolic 
acid) (LA:GA 60:40, MW 4,000 g/mol ) was purchased from Polyscitech Inc. 
Polyethylene glycol (MW 20,000 g/mol) was purchased from Fluka. Common organic 
solvents were used as purchased. Ethanol (99.9%, HPLC grade) was purchased from 
Sigma-Aldrich. Dichloromethane (99.9%, HPLC grade) was purchased from 
Sigma-Aldrich. Carbon dioxide (99.8+%, bone dry grade) pressurized with helium 
was purchased from Airgas. 
3.2 Results and Discussion 
3.2.1 Optical Microscopy 
RESS recrystallized ibuprofen particles and co-precipitated ibuprofen/polymer 
particles were characterized using optical microscope equipped with an ICCD camera. 
Sample images of particles produced at 140 bar and 56 °C are shown in Figure 3.1.  
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a. RESS ibuprofen b. RESS PLLA c. RESS ibuprofen/PLLA 
   
d. RESS ibuprofen e. RESS PLGA f. RESS ibuprofen/PLGA 
   
g. RESS ibuprofen h. RESS PEG i. RESS ibuprofen/PEG 
Figure 3.1  Optical microscopy images of pure RESS ibuprofen (a, d, g) particles 
pure RESS polymer particles (b, e, h) and RESS co-precipitated ibuprofen/PLLA, 
ibuprofen/PLGA, ibuprofen/PEG composite particles (c, f, i). 
3 μm 3 μm 3 μm 
3 μm 3 μm 3 μm 
3 μm 3 μm 3 μm 
43 
 
In this run, ibuprofen and the polymer were loaded to the respective extraction 
vessels with the mass ratio of 1:4. The co-precipitated particles are larger than the 
particles produced in expansion of supercritical solutions containing single 
components. Amorphous polymer PLGA has lower molecular weight compared to 
PLLA and PEG, which are semi crystallized polymers, respectively. As it was found, 
at the conditions used in this work the concentration of the SC solutions is governed 
by the transport phenomena rather than by the solubility of the solutes. Dissolution of 
polymers is accompanied by the plasticization and swelling caused by the penetration 
of CO2 into the polymer (35). PLGA has lower molecular weight and is amorphous, 
both factors increasing the rate of penetration of CO2 molecules (49). This leads to 
higher concentrations of PLGA in the SC solutions, and, subsequently, to larger 
particles.  
3.2.2 Particle Size Distribution 
To evaluate the particle size distribution, 30 images of each sample were randomly 
captured, containing ca. 300 particles. The distribution functions were obtained by 
manually measuring each particle area using Image-Pro Plus 6.0 software and 
calculating their equivalent diameter (according to the equation: A = (d/2)
2
, where A 
is the spot area, and d is the equivalent diameter). The size distributions of the 
ibuprofen particles obtained by RESS re-crystallization at different conditions are 
shown in Figure 3.2. The average particle size depends on the pre-expansion 
temperature and pressure. The load of ibuprofen in the extraction vessel also has 



















Figure 3.2  The particle size distribution of RESS recrystallized ibuprofen produced 
at different conditions. a: 80 bar 56 °C, b: 139 bar 42 °C, c: 154 bar 53 °C, d: 167 bar 
51 °C, e: 224 bar 43 °C, and f: 237 bar 44 °C. 
 
3.2.3 Kinetics of Dissolution of Produced Powders 
Dissolution kinetics of the produced powders was measured at ambient temperature 
(25.0 ± 0.5 °C) as well as human body temperature (37.0 ± 0.5 °C). Weighed samples 
sieved through a 150 μm mesh were introduced into 500 mL of distilled water. The 
flask was continuously stirred at 50 rpm using a paddle stirrer. Aliquots (3 mL) were 
sequentially withdrawn at specific time intervals. After withdrawal of a sample, equal 
amount of fresh distilled water was added to the solution. The maximum dilution of 
the solution caused by this sampling procedure did not exceed 12 %. The withdrawn 
samples were filtered through a 0.22 μm membrane filter (Costar, USA). The amount 
of ibuprofen in the withdrawn samples was determined by measuring the absorbance 
at 222 nm wavelength using a UV-VIS spectrophotometer (SHIMADZU Corporation). 
a b c 
d e f 
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Calibration experiments for UV-Vis absorbance at 222 nm were performed on 
different concentrations of standard ibuprofen solution. A linear regression line was 
drawn. The extinction coefficient measured using standard solutions of ibuprofen in 







Figure 3.3 shows the temporal profiles of the dissolution of the original 
material as well as the produced powders at 20 °C. The dissolution rate coefficient kw 
is used as a basis for comparison of the dissolution rates. It is defined as the reciprocal 
time at which at which 63.2% (1-e
-1
) of the original amount of the drug is dissolved 
(50). The dissolution rate coefficient of the RESS micronized ibuprofen is 0.002 min
-1
, 
which is two times faster than that of the original material. The micronized ibuprofen 
agglomerates upon deposition, which leads to a relatively slow dissolution. The 
ibuprofen composites dissolve much faster than both the original material and the 
RESS recrystallized pure ibuprofen. This is due to the polymer shell between the drug 
particles which serves as a protecting layer which efficiently prevents the drug 
particles from agglomeration. The dissolution rate coefficients of the RESS 





, and 0.02 min
-1
, respectively. These dissolution rates are 
respectively nine, eighteen, and twenty times faster than the dissolution rate of the 
unprocessed ibuprofen. Polymer PLLA is a highly crystalline and poorly soluble in 
water biopolymer. Ibuprofen processed with PLLA presumably dissolves by diffusion 

































Figure 3.3  Temporal dissolution profiles at 25 °C. Squares - pure ibuprofen, circles 
- RESS recrystallized ibuprofen, triangles-up - RESS co-precipitated ibuprofen with 
PLLA (ibuprofen/PLLA), triangles-down - RESS co-precipitated ibuprofen with 
PLGA (ibuprofen/PLGA), and diamonds - RESS co-precipitated ibuprofen with PEG 
(ibuprofen/PEG) (each point is average of three experiments). The horizontal line 





Polymer PEG is a highly water soluble polymer. PLGA dissolved in water 
undergoes fast degradation caused by hydrolysis of its ester linkages (51). Dissolution 
of PEG in water is fast (52). Due to the fast degradation or dissolution of the 
polymeric binders in the ibuprofen/PLGA and ibuprofen/PEG composts, these 
powders dissolve much faster. 
Similar measurements were also performed at the human body temperature 
37 °C. In these experiments, distilled water is still used as the dissolution medium. 
The results are shown in Figure 3.4. At this temperature the dissolution process is 
significantly faster than the dissolution process examined at 25 °C. This is due to the 
increase of the water solubility of ibuprofen ca. two times compared to the solubility 
at 20 °C (53). The dissolution rate coefficient of unprocessed ibuprofen at 37°C is 
0.015 min
-1
, which is ca. fifteen times larger than at 25 °C. The dissolution rate 
coefficient of RESS recrystallized ibuprofen and RESS co-precipitated 
ibuprofen/PLLA is two times larger than that of unprocessed ibuprofen, and for the 
RESS co-precipitated ibuprofen/PLGA and ibuprofen/PEG about, three times larger. 
Ibuprofen co-precipitated with PEG is completely dissolved in 45 min while only 71 % 
of the unprocessed ibuprofen is dissolved in 120 min. The dissolution rate coefficient 




Table 3.1  Dissolution Rate Coefficient (kw) for Unprocessed Ibuprofen, RESS 
Recrystallized Pure Ibuprofen and RESS Co-precipitated Ibuprofen/PLLA, 
Ibuprofen/PLGA, and Ibuprofen/PEG 












RESS at 154 bar, 53 °C, 







RESS at 148 bar, 55 °C, 







RESS at 144 bar, 63 °C 







RESS at 140 bar, 63 °C 






The RESS recrystallized ibuprofen released faster than the unprocessed 
ibuprofen mainly due to the size reduction of the particles. As shown in Figure 3.4, in 
the first 60 min, it is released faster than the RESS co-precipitated ibuprofen/PLLA. 
PLLA coated ibuprofen is presumably released by diffusion through the PLLA 
polymer layer, which hinder dissolution, compared to the dissolution of the pure 
micronized ibuprofen particles. However, it might be expected, that pure micronized 
ibuprofen powder contains a fraction of larger agglomerated particles, which would 
slow down the dissolution at the later stages of the process. PLGA undergoes fast 

















Figure 3.4  Temporal dissolution profiles at 37 °C. Squares - pure ibuprofen, circles 
- RESS recrystallized ibuprofen, triangles-up - RESS co-precipitated ibuprofen with 
PLGA (ibuprofen/PLGA), triangles-down - RESS co-precipitated ibuprofen with 
PLLA (ibuprofen/PLLA), and diamonds - RESS co-precipitated ibuprofen with PEG 
(ibuprofen/PEG) (each point is average of three experiments). The horizontal line 
corresponds to 63.2% of ibuprofen released. 
 
Composites of micronized ibuprofen with these two polymers exhibit 
higher dissolution rates. PLGA is an amorphous polymer with 60:40 mole ratio of 
lactide to glycolide randomly blocked monomers. PLGA hydrolysis leads to lactide 
and glycolide monomers breaking long polymer chains to shorter chains. This 
facilitates permeation of water towards ibuprofen as well as escape of ibuprofen into 
the solution. The release of ibuprofen in the case of the ibuprofen/PLGA composite is 
even faster than the ibuprofen/PEG composites during the initial 30 min of the 
process, as shown in Figure 3.4. Short induction periods in the dissolution of 





presumably to the dissolution of the polymers which precede release of ibuprofen into 
the solution. 
To check whether UV absorption of dissolved polymers interferes with the 
ibuprofen absorption at 222 nm, additional experiments on dissolution of pure 
polymers in water were performed at 37.0 ± 0.5 °C. The polymers were allowed to 
dissolve in water when agitated with 50 rpm for 120 min. The dissolved amounts 
were evaluated by measuring the absorbance at 240 nm (54), 270 nm (51), and 510 
nm (55) for PLLA, PLGA, and PEG, respectively. The UV absorbance of the three 
polymers is summarized in table 3.1. 
 
Table 3.2  Polymer UV Absorbance from Literature 




















PLLA 240 nm not available insoluble In chloroform 
(54) 
PLGA 270 nm not available 
 
insoluble In phosphate buffer 
solution (51) 
PEG 510 nm 1.37x10
5
 630 mg/mL In Dragendorff 
reagent (55) 
 
In the case of PEG, maximum absorbance at 510 nm was reached at 5 min, 
with subsequent decline due to the dilution caused by the sample withdrawal 
procedure. In the case PLGA, no absorbance was detected. The PLGA samples after 
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the procedure were extracted, dried and weighed. The weight loss was 10%, 
indicating that this amount of the polymer was left in the solution. However, no 
absorbance at 270 nm was detected. In the case of PLLA, no weight loss of the 
sample was detected, confirming that PLLA is not water soluble. Finally, for all three 















Figure 3.5  Control experiments on the dissolution of pure polymers at 37°C in 
comparison with the dissolution of unprocessed ibuprofen. Absorbance is measured at 
222 nm. Squares - PLLA precursor, circles - PLGA precursor, triangles-up - PEG 
precursor, and triangles-down - unprocessed ibuprofen. 
 
Ibuprofen is a weak acid. Its dissolution rate could be influenced by the 
increase of the acidity of the dissolution medium. Therefore, a buffer solution would 
be required to maintain a constant pH. However, in this study, the dissolution medium 




10 mg of ibuprofen were dissolved in 500 ml of distilled water. The final pH of the 
solution is 4.4. 
Rivera-Leyva (56) et al. studied the dissolution kinetics of commercial 
ibuprofen suspension. The dissolution rate coefficient in a buffer medium with 
pH=7.2 is 0.03 min
-1
, and in a buffer medium with pH=4.5 is 0.02 min
-1
. In the buffer 
medium with pH=7.2 ibuprofen was 100% released in 60 min. In the pH=4.5 buffer 
medium, 90% of ibuprofen was released in 120 min. These measurements 
demonstrated that the dissolution of ibuprofen is influenced by the acidity of the 
medium. Although in our experiments the measurements were performed in the 
conditions of changing pH in the dissolution process, the conclusions on the relative 






MECHANISM OF PARTICLE FORMATION IN RESS 
4.1 Spray-drying Model 
Spray-drying is a conventional method widely used to produce small particles. In the 
spray-drying process, a liquid solution is first broken into millions of droplets which 
form a spray, this process is called atomization (57). Then the spray contacts with the 
drying medium, usually a heated air or inert gas, where evaporation occurs.. After that 
the dried product is collected at the base of the drying chamber.  In the spray-drying 
process, the particle size as well as the particle size distribution is controlled by the 
droplet size distribution and the solute concentration in the solution. 
4.2 Tentative Particle Formation Mechanism 
In the previous work it was shown that the particle size of particles precipitated by 
RESS is significantly larger than the particle size expected due to the homogeneous 
nucleation and growth of the solute (58). For RDX, the predicted maximum particle 
size by the homogeneous nucleation and growth model was ca. 20 nm,(REFERENCE) 
with the observed size of about 200 nm (depending upon the conditions), which 
translates into the 1000 times discrepancy in the particle mass. For this specific 
system (RDX precipitation) it was unambiguously shown that the homogeneous 
precipitation and growth is not the mechanism responsible for the particle formation 
in the RESS process. Alternatively, a modified spray-drying model was proposed (58). 
This model is based on the observation that the RESS of SC solutions in CO2 is 
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accompanied by condensation (with subsequent evaporation) of carbon dioxide. Then 
the process is equivalent to the spray-drying process which differs mainly by the fact 
that the condensed phase appears in the stage of the spray formation. Additional 
feature is the impact of the dissolved solute on the droplet (or crystals) condensation 
dynamics and the size distribution. The model, in the first approximation, predicts the 
volume of the solute particles to be proportional to the concentration of the solution, 
or, alternatively, the diameter to be proportional to the cubic root of the concentration 
 




where d is the diameter of the solute particle formed, and C is the mass concentration 
of the solute in the supercritical solution.  
To verify the particle formation mechanism in the case of ibuprofen precipitation,  
additional experiments on ibuprofen particles formation by RESS when the 
concentration of dissolved ibuprofen was systematically varied were carried out. The 
amounts of the dissolved ibuprofen and the polymers were accurately measured by 
weighing the extraction vessels before and after each run. It was found that the weight 
losses did not correspond to the solubility of these compounds in supercritical carbon 
dioxide, and that the solution was not saturated either with ibuprofen or the polymers. 
In addition, the weight loss was increasing with the initial load. These observations 
indicate that the dissolved amounts are controlled mainly by other factors, such as the 
transport and the dissolution rates.  
55 
 
The main observations of this study were rationalized based on the modified 
spray-drying mechanism (58).  
Upon expansion, the stream of the supercritical solution undergoes fast 
cooling which leads to the formation of liquid carbon dioxide or, at lower downstream 
pressures, dry ice. The entrained quantities of the solutes in the droplets are 
proportional to their concentrations in the supercritical solution. Subsequently, carbon 
dioxide evaporates or sublimes, leaving solid composite particles consisting of the 
















Figure 4.1  The particle size distribution of RESS recrystallized ibuprofen produced 
at different conditions. a: 80 bar 56 °C, b: 139 bar 42 °C, c: 154 bar 53 °C, d: 167 bar 
51 °C, e: 224 bar 43 °C, and f: 237 bar 44 °C. Filled squares are the mean diameter, 
open squares are the diameters in the maxima of the distribution functions, and the 
error bars are ±1standard deviation. 
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To check the particle size dependence on the solution concentration predicted 
by the modified spray-drying mechanism (4.1) recrystallization of ibuprofen by RESS 
was conducted at different conditions. Concentration of ibuprofen in the supercritical 
solutions was varied by varying the load and pressure. Figure 4.1 shows the plot of 
the average particle size vs. the cubic root of the solution concentration. The measured 






SOLUBILITY OF COMPOUNDS IN SUPERCRITICAL CARBON DIOXIDE 
5.1 Polymer Dissolution in Liquid Solvent 
The process of polymer dissolution differs significantly from the process of 
dissolution of material made of small size small molecules. For non-polymeric 
materials, the rate of the “external” mass transfer controls the rate of the dissolution 
process. For polymers, the dissolution rate is usually  controlled either by the solvent 
diffusion or the disentanglement of the polymer chains (59). As a result, polymers do 
not dissolve “instantaneously”. 
Crank (60) summarized the structure of the glassy polymers during dissolution 
above its gel temperature.  
1. The infiltration layer: the solvent molecules penetrate into the polymer free 
volumes. 
2. The solid swollen layer: more and more solvent penetrate into the polymer, new 
holes created but the polymer is still in the glassy state. 
3. The gel layer: as the polymer becomes swollen by the solvent molecules, it is in 
the rubber-like state.  
4. The liquid layer: this layer surrounds the internal undissolved solid layers. 
For dissolution below a certain temperature, the gel layer is not formed. 
Instead extensive cracking inside the polymer matrix occurs which facilitates the 
solvent penetration. This specific temperature is defined as the gel temperature of the 
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polymer. Therefore, the variation in the free volume and the stiffness of the polymer 
play an important role for controlling the polymer behavior  
Higher molecular weight polymers dissolve slower because they have higher 
degree of chain entanglement which will make the swelling process much longer than 
that for the lower molecular weight polymers. Also they are packed more densely 
with less pores and cracks or other kind of imperfections (49), which slow down the 
solvent diffusion process. 
From the thermodynamic view, the dissolution of a polymer in a solvent is 
governed by the free energy of mixing (61): 
 
ΔGm = ΔHm - TΔSm (5.1) 
 
where ΔGm is the molar Gibbs free energy of mixing, ΔHm is the enthalpy  of 
mixing, T is the absolute temperature, and ΔSm is the entropy of mixing. Since the 
dissolution of polymers is usually accompanied with a small positive entropy change, 
the enthalpy change becomes the controlling factor. The enthalpy of mixing is given 
by 
 










Φ1 Φ2 (5.2) 
 
where Vmix is the volume of the mixture, ΔE
V
i is the energy of vaporization of species 
i; Vi is the molar volume of species i; and Φi is the volume fraction of i in the mixture.  
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where E is defined as the increase in the internal energy per mole of the material if in 
the process of elimination of all of the intermolecular forces E is also called the the 
cohesive energy. V is the volume of the material per mole, E/V is the cohesive energy 




in Equation 5.2. 
Therefore, the enthalpy of mixing can be rewritten as: 
 
ΔHm = Vmix [(δ1 - δ2)]
2 
Φ1 Φ2 (5.4) 
 
In order to the dissolution process to occur spontaneously, the Gibbs free energy of 
mixing must be negative. Therefore the ΔHm term should be smaller than the TΔSm 
term in Equation 5.1. From Equation 5.4, to make ΔHm small, δ1 - δ2 should be as 
small as possible. It means that the solubility parameter difference between the solute 
and solvent should be small in order to make the solute readily dissolved in the 




Table 5.1 Solubility Parameter Calculations of RDX and Binders 












RDX  3 NO2 
3 CH2 
3N 
6 member ring  
1.519×10
4
  137.8  10.49 
VDF-HFP22  5 CF2 
4 CH2 
1 CF3 
1 C  
1 F  
10 main chain 
1.219×10
4
  255.7  6.910  






1 6-member ring  
9.630×10
3
  94.50  10.10  














Fedors et al. (62) developed the group contribution method to estimate the  












Δei is atomic and group contributions to the energy of vaporization per mole, and Δvi 
is the atomic and group contributions to the molar volume at a specific temperature. 
At room temperature, δCO2 equals 5.96 (61) and δRDX equals 10.49 (7). The calculated 
solubility parameter at room temperature of the chemicals used in this work, which 
was listed in Table 3. We find that VDF-HFP22 is the most favored in CO2. 
5.2 Polymer Dissolution in Carbon Dioxide 
The polymer dissolution in supercritical carbon dioxide will include several steps (63) 
as shown in Figure 5.1: 
1. CO2 molecule absorb on the surface of the polymer.CO2 molecule diffuses into 
the polymer matrix. 
2. CO2 concentration inside the polymer reaches a critical concentration where the 
polymer chains have enough space to disentangle from each other and start to 
dissolve into the solvent. The dissolution rate is low, the process is still CO2 
adsorption/absorption controlled. 
3. The polymer dissolution rate increases to be higher than the CO2 
adsorption/absorption rate. The polymer dissolution occurs much faster, the 
process become polymer dissolution controlled. 
For most polymers, its solubility in supercritical carbon dioxide increases 
dramatically and non-linearly as the pressure increased. This is because at higher 
pressure the density of carbon dioxide is much higher. The solubility of polymers 
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in CO2 drops sharply as a function of molecular weight. However, complete 
dissolution of the polymer film is normally not achieved. The non-soluble part 











Figure 5.1  Schematic showing the difference phenomena involved during the 
dissolution process of polymer films (63). 
 
5.2.1 Factors that Influence Polymer Solubility in Supercritical Carbon Dioxide 
From lattice solution theory, three factors may influence polymer solubility in 
supercritical carbon dioxide, which are solute-solute interactions, solute-solvent 
interactions, and solvent-solvent interactions. CO2-CO2 interaction is negligible as 
compared to the other two factors. A difference in the solubility parameter between a 
polymer and carbon dioxide would be a representative factor for solute-solvent 
interaction. O’Neil (64) stated that the surface tension of the polymer is a reliable 
measurement of cohesive energy density for the polymer-polymer interactions. From 
the cloud point measurement, it is concluded that polymers solubility in carbon 
dioxide at temperatures below 80 °C is inversely proportional to the surface tension of 
the polymer, which demonstrated that the solubility is governed primarily by the 




The free volume inside the polymer is also an important factor that influences the 
polymer solubility in supercritical carbon dioxide (65). It is known, that glassy 
polymers have lower solubility and dissolution rate compared to completely 
amorphous polymers (65). The polymers which were used to produce composites with 
ibuprofen have different crystallinity: PLLA has crystallinity 37% (66), PEG and 
PLGA are amorphous. This explains the trend in the particle size of these polymers 
when crystallized by RESS separately.   
5.2.2 Polymer Solubility in Supercritical Carbon Dioxide 
Rindfleish (65) experimentally tested cloud-point data of polymers and copolymers in 
supercritical CO2 up to 27 ℃ and 3000 bar. The solubility of PS (MW 1850 g/mol) 
is low and below the sensitivity (0.1 wt %) of the cloud-point technique. At 70 ℃, 
VDF-HFP22 has cloud-point pressure of 700 bar. At higher temperatures, the 
cloud-point pressures are even higher. VDF-HFP22 is relatively more soluble than PS 
in CO2 because of its fluorine content and the copolymer block in the chain. Also, PS 
has a Tg of 103 ℃, which indicates that PS has a stiffer chain backbone and have less 
rotational flexibility of the chain segments. This results in a higher entropy penalty for 
CO2 to dissolve PS. 
Fluorinating a hydrocarbon polymer improves its solubility in CO2, because 
the carbon atom in CO2 and the fluorine atom in the polymer repeating unit form a 
weak complex C-F at low temperatures (67). CO2 can act as an electron acceptor to 
form Lewis acid-base complexes with polymers that possess electron donating groups, 
such as fluorine atoms. The hexafluoro propylene (HFP) comonomer disrupts the 
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stereo regularity of -VDF and thus renders it amorphous. Vinylidene fluoride (VDF) 
co-monomer introduces polarity into the backbone of VDF-HFP22. Dipole of –VDF 
interacts favorably with the quadrupole of CO2, which overshadows CO2-CO2 
quadrupolar interactions. VDF-HFP22 can dissolve in CO2 at modest pressures and 
temperatures as low as 0 ℃ due to the dominance of the polar interactions at low 
temperatures. O’Neil (64) et al. experimentally measured the solubility of PS at 207 
bar, and 35 ℃, The low molecular weight PS (MW 500 g/mol) is slightly soluble (« 
0.1 wt %). However, the PS with MW of 1850 g/mol is “insoluble” in supercritical 
CO2. Then the PS used in the current experiments with the MW of 250000 g/mol 
should be considered as insoluble in CO2 under the same conditions. As mentioned in 
our previous work (1), RDX is slightly soluble (0.2 wt %) in CO2 at 35 ℃, 200 bar. 





(62). At 25 ℃, δ (CO2) is 5.96, δ (RDX) is 10.49 (7) and δ (PS) (density of 
1.06 g / cm
3
) is 9.10 (68). Based on the group contribution method as shown in Table 
5.1., δ (VDF-HFP22) is calculated as 6.91. VDF-HFP22 has the closest δ value to CO2, 
as compared to RDX and PS, which means it is more favorable in CO2 at 25 ℃. This 
is in accord with the cloud point measurements. The solubility in CO2 can be arranged 








The technique of production of composite nano- and micron sized materials using 
Rapid Expansion of Binary Supercritical Solutions was explored and characterized. 
The technique was applied to two systems: production of nanocrystalline polymer 
coated energetic materials and micron sized drug – biocompatible polymer 
composites. The specific results are: 
Nanoparticles of RDX coated with PS or VDF-HFP22 polymer films were 
produced by co-precipitation in rapid expansion of supercritical solutions (RESS). 
The morphology of produced nanoparticles was characterized by SEM and TEM. The 
size of produced RDX nanoparticles is ca. 100 nm. The X-ray powder diffraction 
indicates that the particles are polycrystalline with crystallite size of 42 nm (similar to 
the crystallite size for pure nano-RDX, 44 nm). However, RDX diffraction indicates 
much larger internal strain of the particles. The RDX mass fraction in the produced 
powders was in the range 70-82%, as analyzed using GC-MS and XRPD. TEM 
analysis of the RDX/PS nanocomposites assisted by selective staining of the polymer 
phase showed ca. 10 nm shell layer of polystyrene on the RDX core. The observations 
indicate core-shell structure of the products rather than separate precipitation of the 
components. RDX was also co-precipitated with AMC, a fluorescent dye compound 
for evaluation using optical fluorescence microscopy with evanescent excitation.  
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Comparison of the usual optical images and the images acquired via fluorescence 
indicates that all produced particles contain the fluorescent dye. No RDX 
nanoparticles free of dye have been observed. 
Micro-particles composite of ibuprofen with bio-compatible polymers were 
also produced by co-precipitation in rapid expansion of supercritical solutions (RESS). 
The morphology of produced nanoparticles was characterized by optical microscopy. 
The size of produced particles is 3-10 microns. Although RESS of pure materials 
produces nano- or micron-sized particles, there are no means to prevent their 
agglomeration. Reduction of the size of particles of energetic materials leads to 
reduction of their sensitivity to external stimuli (38). Micronization of drug particles 
enhances their bioavailability and the dissolution rate. Co-precipitation of a drug and 
bioavailable polymers composites can either accelerate or slow down the drug release 
depending on the chosen polymer. Kilogram to 100 kg level quantities can be 
produced. The particles size is controlled by varying the experimental conditions (e.g., 
pressure, load). RESS co-precipitation is a simple one step process. It could be binary 
or multi-component production. It is environmental friendly, organic solvent free, 
clean and economic. 
The product was evaluated with SEM, TEM, XRD, and GC-MS. Core-shell 
structure of RESS co-precipitated RDX/PS was demonstrated. It will reduce 
agglomeration of the particles and enhance functionality. The dissolution profile was 
examined on RESS co-precipitated ibuprofen and polymers. Remarkable dissolution 
enhancement was achieved by the co-precipitated composite as compared to 
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unprocessed ibuprofen. The approach can be extended to other energetic or drug 
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